Acute phase levels of ADAM 23 (Disintegrin and metalloproteinase domain-containing protein 23) were associated to both acute stroke severity, 3-month and 7-year neurological outcome in our study, leading us to hypothesize that causal associations of importance in the early post-stroke phase might be represented among our findings. This evidence concerns the gene ADAM23 and stroke disorder.